Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types

Int J Gynecol Cancer. 2012 Oct;22(8):1398-406. doi: 10.1097/IGC.0b013e3182664b6b.

Abstract

Background: Persistent infection with high-risk (HR) human papillomavirus (HPV) is a well-recognized cause of cervical cancer, but little is known about the situation in Laos. The aims of the study were to determine the prevalence of HR-HPV among Lao women and to evaluate the use of a filter paper card (FTA Elute Micro Card) for collection of cervical cells in the humid tropical climate.

Methods: This is a cross-sectional study including 1922 women from 3 provinces in Laos. During a gynecological examination, cervical cells were collected and applied to the FTA card followed by HPV typing using a real-time polymerase chain reaction (PCR)-based assay.

Results: Overall, 213 of the 1922 women were positive for HR-HPV (11%). The most common type was the group HPV33/52/58 (3%), followed by the single type 16 (2%) and the group 18/45 (1%), respectively. Only 11 cards (0.6%) did not contain a sufficient amount of genomic DNA for polymerase chain reaction-based analysis.

Conclusions: The prevalence of HR-HPV infections in Laos is similar to other Asian countries, and 40% of the women with an HR-HPV infection will be target of the present HPV vaccines. The FTA card is suitable for collection of cervical cells for HR-HPV typing in tropical conditions. This information is important for planning and establishing primary and secondary prevention of cervical cancer in Laos.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cervix Uteri / virology
  • Child
  • Cross-Sectional Studies
  • DNA, Viral / genetics
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Laos / epidemiology
  • Middle Aged
  • Neoplasm Staging
  • Paper*
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / virology
  • Patient Identification Systems*
  • Prevalence
  • Prognosis
  • Real-Time Polymerase Chain Reaction
  • Risk Factors
  • Specimen Handling / instrumentation*
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / virology
  • Vaginal Smears / instrumentation*
  • Young Adult

Substances

  • DNA, Viral